Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Current Leases: 2011-2025

Historic Current Leases for Arrowhead Pharmaceuticals (ARWR) over the last 10 years, with Sep 2025 value amounting to $7.3 million.

  • Arrowhead Pharmaceuticals' Current Leases rose 14.93% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 14.93%. This contributed to the annual value of $7.3 million for FY2025, which is 14.93% up from last year.
  • Per Arrowhead Pharmaceuticals' latest filing, its Current Leases stood at $7.3 million for Q3 2025, which was up 3.98% from $7.0 million recorded in Q2 2025.
  • Arrowhead Pharmaceuticals' Current Leases' 5-year high stood at $10.6 million during Q3 2023, with a 5-year trough of $1.3 million in Q1 2021.
  • In the last 3 years, Arrowhead Pharmaceuticals' Current Leases had a median value of $6.3 million in 2024 and averaged $5.9 million.
  • Its Current Leases has fluctuated over the past 5 years, first surged by 280.51% in 2023, then crashed by 39.96% in 2024.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Current Leases (Quarterly) stood at $2.8 million in 2021, then fell by 5.73% to $2.7 million in 2022, then increased by 28.42% to $3.4 million in 2023, then skyrocketed by 91.76% to $6.6 million in 2024, then climbed by 14.93% to $7.3 million in 2025.
  • Its Current Leases stands at $7.3 million for Q3 2025, versus $7.0 million for Q2 2025 and $6.8 million for Q1 2025.